Form 8-K - Current report:
SEC Accession No. 0001293971-24-000060
Filing Date
2024-10-04
Accepted
2024-10-04 16:04:42
Documents
13
Period of Report
2024-09-30
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K blue-20240930.htm   iXBRL 8-K 29079
  Complete submission text file 0001293971-24-000060.txt   153823

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blue-20240930.xsd EX-101.SCH 1913
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blue-20240930_lab.xml EX-101.LAB 21880
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blue-20240930_pre.xml EX-101.PRE 12516
15 EXTRACTED XBRL INSTANCE DOCUMENT blue-20240930_htm.xml XML 2718
Mailing Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145
Business Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145 339-499-9300
bluebird bio, Inc. (Filer) CIK: 0001293971 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35966 | Film No.: 241354907
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)